Has Radhika Grandhe, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,042 in general payments to Radhika Grandhe, MD across 79 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Radhika Grandhe, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Radhika Grandhe, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Radhika Grandhe, MD

Anesthesiology · Albuquerque, NMNPI 1174858443

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Nevro Corp. at 31.7% of the total. Reporting peaked in 2023 at $2,231 and has fallen 84.4% since, to $347 in 2025. Among anesthesiology clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,042in general payments, 2019–2025

Across 79 payments — averaging $101.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nevro Corp.$3K
Relievant Medsystems, Inc.$2K
Nalu Medical, Inc.$1K
Medtronic$970
Abbott$861
Stimwave Technologies Incorporated$273
plus $596 from 6 others

$3,840in research payments, 2019–2025

Across 1 payment — averaging $3840.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bioventus LLC$4K

What the payments were for

Travel & lodging$2,98837%
Food & beverage$4,33154%
Education$7239%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nevro Corp.	31	$2,552
Relievant Medsystems, Inc.	10	$1,663
Nalu Medical, Inc.	10	$1,126
Medtronic	4	$970
Abbott	10	$861
Stimwave Technologies Incorporated	2	$273
SPR Therapeutics, Inc	4	$208
Globus Medical	2	$174
AbbVie	1	$104
Pacira Therapeutics, Inc.	2	$41
Stryker	2	$38
UCB, Inc.	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Intracept$5,663
Omnia$1,609
Nalu Neurostimulation System$982
ADAPTIVESTIM$597
ETERNA$421
RESTORE$356
Senza Spinal Cord Stimulation System$331
Senza$289
Proclaim Family of SCS IPGs$167
UBRELVY$104

How this compares

$8,042 in reported general payments places this provider in the 95th percentile of 174 anesthesiology providers in New Mexico.

See all anesthesiology providers in New Mexico →

Medicare billing

Part B allowed, 2024

$25,992

Medicare patients

111

Services billed

243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	20	$456
Tramadol Hcl	18	$151
Gabapentin	13	$151

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Albuquerque

Deepak PadmanabhaAlbuquerque$13K
Elizabeth BakerAlbuquerque$8K
Douglas BrownAlbuquerque$3K
Elliot MarcusAlbuquerque$2K
Raul MarquezAlbuquerque$2K
Casey DellabarcaAlbuquerque$1K
Abhishek SalujaAlbuquerque$1K
Timothy O BrienAlbuquerque$1K
Gerold BlazekAlbuquerque$1K
Lisa HuntAlbuquerque$996

See the full list for New Mexico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →